Aster Capital Management DIFC Ltd Boosts Holdings in Kenvue Inc. $KVUE

Aster Capital Management DIFC Ltd lifted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 1,241.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 49,085 shares of the company’s stock after buying an additional 45,427 shares during the quarter. Aster Capital Management DIFC Ltd’s holdings in Kenvue were worth $797,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the stock. AlphaCore Capital LLC boosted its position in Kenvue by 9.9% during the 2nd quarter. AlphaCore Capital LLC now owns 5,287 shares of the company’s stock valued at $111,000 after acquiring an additional 476 shares in the last quarter. Empirical Finance LLC lifted its stake in shares of Kenvue by 1.8% in the 2nd quarter. Empirical Finance LLC now owns 28,309 shares of the company’s stock valued at $593,000 after purchasing an additional 491 shares during the period. J.W. Cole Advisors Inc. boosted its position in shares of Kenvue by 3.8% during the second quarter. J.W. Cole Advisors Inc. now owns 15,488 shares of the company’s stock valued at $324,000 after purchasing an additional 574 shares in the last quarter. Spire Wealth Management boosted its position in shares of Kenvue by 13.5% during the second quarter. Spire Wealth Management now owns 4,863 shares of the company’s stock valued at $102,000 after purchasing an additional 580 shares in the last quarter. Finally, Versor Investments LP grew its stake in Kenvue by 2.8% in the third quarter. Versor Investments LP now owns 26,016 shares of the company’s stock worth $422,000 after purchasing an additional 716 shares during the period. 97.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on the company. Edward Jones lowered Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Barclays lifted their price target on shares of Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a research report on Monday, November 10th. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Finally, Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and decreased their target price for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Three investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat, Kenvue has a consensus rating of “Hold” and an average target price of $19.50.

Insider Activity

In other Kenvue news, Director Jeffrey C. Smith acquired 3,200,000 shares of the company’s stock in a transaction that occurred on Friday, December 12th. The shares were bought at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the acquisition, the director owned 27,307,632 shares in the company, valued at $474,333,567.84. This represents a 13.27% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.68% of the stock is currently owned by corporate insiders.

Kenvue Trading Up 1.2%

Kenvue stock opened at $19.00 on Friday. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.69. The business’s fifty day moving average is $17.68 and its 200 day moving average is $17.57. The stock has a market capitalization of $36.42 billion, a PE ratio of 24.68, a price-to-earnings-growth ratio of 4.30 and a beta of 0.59.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $3.68 billion. During the same period in the prior year, the firm earned $0.26 EPS. The company’s revenue was up 3.2% compared to the same quarter last year. On average, sell-side analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 annualized dividend and a yield of 4.4%. The ex-dividend date of this dividend was Wednesday, February 11th. Kenvue’s dividend payout ratio (DPR) is presently 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.